MedTech Acquisition announced that it closed its IPO of 25 million units, which included 3 million units pursuant to the partial exercise of the underwriters’ over-allotment option. The offering was priced at $10 per unit, resulting in proceeds of $250 million. The raise was 25 percent greater than the initial registration for 20 million units.
MedTech is focused on the US medical technology and healthcare sectors.
The company’s units trade on the Nasdaq under MTACU. Read more.
